StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.50−0.17 (-3.64%)

Close on Nov 18, 2026Market cap $350.75MP/E –Yield –

CorMedix net income

Net income is the profit left for shareholders after every expense, interest and tax.

CorMedix's net income for the twelve months ending Jun 30, 2026 was $187.17M, up 265.9% year over year. For fiscal 2025 it was $163.06M. The highest annual figure on record is $163.06M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$163.06M–
FY2024Dec 31, 2024-$17.93M–
FY2023Dec 31, 2023-$46.34M–
FY2022Dec 31, 2022-$29.70M–
FY2021Dec 31, 2021-$28.21M–
FY2020Dec 31, 2020-$22.03M–
FY2019Dec 31, 2019-$16.43M–
FY2018Dec 31, 2018-$26.83M–
FY2017Dec 31, 2017-$33.01M–
FY2016Dec 31, 2016-$24.64M–
FY2015Dec 31, 2015-$18.19M–
FY2014Dec 31, 2014-$20.45M–
FY2013Dec 31, 2013-$9.13M–
FY2012Dec 31, 2012-$3.38M–
FY2011Dec 31, 2011-$6.67M–
FY2010Dec 31, 2010-$10.91M–
FY2009Dec 31, 2009-$8.12M–
FY2008Dec 31, 2008-$9.00M–
FY2007Dec 31, 2007-$7.24M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$25.99M+31.1%
Q1 FY2026Mar 31, 2026$38.60M+87.0%
Q4 FY2025Dec 31, 2025$14.02M+4.1%
Q3 FY2025Sep 30, 2025$108.56M–
Q2 FY2025Jun 30, 2025$19.83M–
Q1 FY2025Mar 31, 2025$20.64M–
Q4 FY2024Dec 31, 2024$13.46M–
Q3 FY2024Sep 30, 2024-$2.78M–
Q2 FY2024Jun 30, 2024-$14.15M–
Q1 FY2024Mar 31, 2024-$14.47M–
Q4 FY2023Dec 31, 2023-$14.75M–
Q3 FY2023Sep 30, 2023-$9.74M–
Q2 FY2023Jun 30, 2023-$11.27M–
Q1 FY2023Mar 31, 2023-$10.57M–
Q4 FY2022Dec 31, 2022-$8.21M–
Q3 FY2022Sep 30, 2022-$6.85M–
Q2 FY2022Jun 30, 2022-$7.60M–
Q1 FY2022Mar 31, 2022-$7.03M–
Q4 FY2021Dec 31, 2021-$7.79M–
Q3 FY2021Sep 30, 2021-$8.57M–
Q2 FY2021Jun 30, 2021-$4.63M–
Q1 FY2021Mar 31, 2021-$7.22M–
Q4 FY2020Dec 31, 2020-$6.09M–
Q3 FY2020Sep 30, 2020-$6.60M–
Q2 FY2020Jun 30, 2020-$3.78M–
Q1 FY2020Mar 31, 2020-$5.56M–
Q4 FY2019Dec 31, 2019-$5.30M-346.9%
Q3 FY2019Sep 30, 2019-$5.26M–
Q2 FY2019Jun 30, 2019-$696.16K–
Q1 FY2019Mar 31, 2019-$5.17M–
Q4 FY2018Dec 31, 2018$2.15M–
Q3 FY2018Sep 30, 2018-$10.24M–
Q2 FY2018Jun 30, 2018-$8.56M–
Q1 FY2018Mar 31, 2018-$10.19M–
Q4 FY2017Dec 31, 2017-$10.31M–
Q3 FY2017Sep 30, 2017-$9.96M–
Q2 FY2017Jun 30, 2017-$5.15M–
Q1 FY2017Mar 31, 2017-$7.60M–
Q4 FY2016Dec 31, 2016-$6.40K–
Q3 FY2016Sep 30, 2016-$9.13M–

More CorMedix figures

See a number that looks wrong?